Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
R G Blanks a Cancer Screening Evaluation Unit, Institute of
Cancer Research, Section of Epidemiology, Sutton, Surrey SM2 5NG, b Office for National Statistics, Demography and Health
Division, London SW1V 2QQ
Correspondence to:
S M Moss s.moss{at}icr.ac.uk
Objective:
To assess the impact of the NHS breast
screening programme on mortality from breast cancer in women aged 55-69 years over the period 1990-8.
Design:
Age cohort model with data for 1971-89 used to
predict mortality for 1990-8 with assumption of no major effect from
screening or improvements in treatment until after 1989. Effect of
screening and other factors on mortality estimated by comparing three
year moving averages of observed mortality with those predicted (by
five year age groups from 50-54 to 75-79), the effect of screening
being restricted to certain age groups.
Setting:
England and Wales.
Subjects:
Women aged 40 to 79 years.
Results:
Compared with predicted mortality in the
absence of screening or other effects the total reduction in mortality from breast cancer in 1998 in women aged 55-69 was estimated as 21.3%.
Direct effect of screening was estimated as 6.4% (range of estimates
from 5.4-11.8%). Effect of all other factors (improved treatment with
tamoxifen and chemotherapy, and earlier presentation outside the
screening programme) was estimated as 14.9% (range 12.2-14.9%).
Conclusions:
By 1998 both screening and other factors, including improvements in treatment, had resulted in substantial reductions in mortality from breast cancer. Many deaths in the 1990s
will be of women diagnosed in the 1980s and early 1990s, before
invitation to screening. Further major effects from screening and
treatment are expected, which together with cohort effects should
result in further substantial reductions in mortality from breast
cancer, particularly for women aged 55-69, over the next 10 years.
Read all Rapid Responses